Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Fond du Lac, WI MSA — September 2026
Fond du Lac jobs shrink while life sciences hiring stays national-tight.
Fond du Lac MSA unemployment rose to 3.2% in August as the metro shed an average 50 jobs monthly, yet national biopharma recruiting remains active with 64% of organizations still hiring despite September layoffs at firms like BioMarin.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Fond du Lac MSA unemployment: 3.2% — Up from stable readings; WI statewide at 2.7-2.9%
- Metro job trend 2026: -50 jobs/month avg — Weakest since 2024; below 2019 employment levels
- Biopharma active recruiting: 64% — Despite Sept layoffs at BioMarin, Bristol Myers nationally
- WI biotech average compensation: $79,796 — Well below Boston/Bay Area premium markets
Key takeaways
Local job losses mask a tighter specialized-talent reality.
Fond du Lac's broader labor market is softening, but the roles life sciences leaders actually compete for — regulatory, CMC, quality — sit in a national market still running hot, with 41% of biopharma organizations expecting more open roles this fall. Local unemployment ticking to 3.2% should not be read as easing pressure on scientific or regulatory hiring.
Wisconsin's pay discount is a recruiting tool with limits.
Average biotech compensation of roughly $79,796 statewide, well below coastal hubs, helps retention economics but does little against scarce specialties like cell/gene CMC or clinical pharmacology where national premiums reach $220K-$520K for director-level process development. Relying on geographic pay discount alone risks losing bids for the hardest-to-fill roles to remote-eligible employers.
Outsourcing capacity nearby changes the build-vs-buy math.
Catalent's Madison site, supporting work from research through early manufacturing, gives Fond du Lac-area organizations a credible CDMO alternative within the state rather than defaulting to coastal or international partners. Headcount planning for quality and process development should weigh this regional capacity before committing to internal build-out in a soft local labor market.
Low-hire, low-fire Wisconsin conditions buy a narrow planning window.
Statewide payroll growth remains muted and WARN activity is down 7% year over year, suggesting reduced poaching risk on existing R&D and QA staff through year-end. That window is likely temporary given accelerating national biopharma recruiting activity, and should inform timing on retention adjustments rather than delay them indefinitely.
Median advertised pay by role — Fond du Lac, WI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $88,178 | $111,019 | $117,649 | Significant increase | $131,354 |
| Clinical Research Associate * | $54,120 | $77,007 | $118,764 | Significant increase | $90,956 |
| Lab Technician * | $38,930 | $45,900 | $49,920 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $84,500 | $108,813 | $108,814 | Significant increase | $104,000 |
| Clinical Data Manager * | $93,991 | $115,389 | $122,805 | Significant decline | $123,031 |
| Biostatistician * | $78,333 | $117,388 | $125,000 | Significant increase | $133,322 |
| Validation Engineer * | $91,500 | $109,273 | $130,000 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Fond du Lac MSA employment continues to contract, averaging a loss of 50 jobs per month through 2026 with the unemployment rate ticking up to 3.2% in August, even as statewide unemployment holds near a two-decade low of 2.7-3.2%. Local softness is concentrated in manufacturing and trade sectors rather than life sciences specifically, but the metro's thin specialized-science labor pool means any R&D, quality, or regulatory opening still draws from a regional talent base stretched by Madison and Milwaukee competition.
What it means
Metro-level job losses do not reflect life sciences demand — national data shows 64% of biopharma organizations still actively recruiting even amid September layoff announcements at firms like BioMarin and Bristol Myers, meaning Fond du Lac-based employers compete against a national floor on regulatory, CMC, and quality talent regardless of local softness. Wisconsin's below-coastal compensation positioning (average biotech pay of $79,796 versus Boston/Bay Area premiums) remains a retention asset only if paired with credible internal mobility, since scarce specialties like DMPK, clinical pharmacology, and manufacturing validation will not clear through local hiring alone. Consider evaluating whether current build-vs-outsource assumptions still hold for CMC and quality roles, given that Catalent's Madison facility signals viable CDMO capacity within commuting distance of the metro.
Looking ahead
Worth watching: Wisconsin's wage growth is decelerating to a projected 3.7% in 2026 from 4.2% in 2025, with inflation potentially erasing real gains. Watch whether this compresses life sciences pay increases toward general-industry norms or whether specialized roles continue to outpace the statewide trend.
Emerging pressure point: National WARN activity includes biopharma names like BioMarin and Bristol Myers alongside Amazon, Meta, and Oracle; monitor whether displaced regulatory or CMC talent from these restructurings enters the Wisconsin candidate pool, which could temporarily ease sourcing for hard-to-fill specialties.
Potential inflection point: Fond du Lac employment remains below 2019 levels with no clear inflection yet visible in September data. A continued 0.8% growth forecast for 2026 suggests any life sciences-specific hiring push will stand out against a flat regional backdrop, useful context for justifying competitive offers internally.
Early indicator: Madison's life science lab vacancy rate edged up to 4%, a modest signal of space tightness rather than acute talent shortage. Track whether lab capacity constraints in the broader Wisconsin ecosystem begin pushing more build-vs-outsource decisions toward CDMO partners like Catalent.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.